 OXFORD, United Kingdom and MARLBOROUGH, Mass., Dec. 16, 2020 GLOBE NEWSWIRE -- Oxford Immunotec Global PLC Nasdaq: OXFD the Company, a global, high-growth diagnostics company, announce the formation and initial meeting of the Global T cell expert consortium GTEC. The GTEC is a community of experts in T cell research, epidemiology, vaccine research and global public health. It aims to be the leading voice for T cell expertise during and beyond the current COVID-19 pandemic. 